Your browser doesn't support javascript.
loading
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis.
Fleischmann, Roy M; Blanco, Ricardo; Hall, Stephen; Thomson, Glen T D; Van den Bosch, Filip E; Zerbini, Cristiano; Bessette, Louis; Enejosa, Jeffrey; Li, Yihan; Song, Yanna; DeMasi, Ryan; Song, In-Ho.
Afiliación
  • Fleischmann RM; Department of Medicine, The University of Texas Southwestern Medical Center and Metroplex Clinical Research Center, Dallas, Texas, USA rfleischmann@arthdocs.com.
  • Blanco R; Division of Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain.
  • Hall S; Department of Medicine, Monash University, Cabrini Health and Emeritus Research, Melbourne, Victoria, Australia.
  • Thomson GTD; CIADS Research, Winnipeg, Manitoba, Canada.
  • Van den Bosch FE; Department of Rheumatology, University Hospital Ghent, Gent, Oost-Vlaanderen, Belgium.
  • Zerbini C; VIB Center for Inflammation Research, Department of Internal Medicine and Pediatrics, University of Ghent, Gent, Oost-Vlaanderen, Belgium.
  • Bessette L; Centro Paulista de Investigação Clinica, São Paulo, Brazil.
  • Enejosa J; Université Laval Faculté de médecine, Quebec City, Québec, Canada.
  • Li Y; Centre de recherche du CHU de Québec-Université Laval, Quebec City, Québec, Canada.
  • Song Y; AbbVie Inc, North Chicago, Illinois, USA.
  • DeMasi R; AbbVie Inc, North Chicago, Illinois, USA.
  • Song IH; AbbVie Inc, North Chicago, Illinois, USA.
Ann Rheum Dis ; 80(4): 432-439, 2021 04.
Article en En | MEDLINE | ID: mdl-33148701

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos / Inhibidores de las Cinasas Janus Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos / Inhibidores de las Cinasas Janus Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos